Loxo Oncology, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 13 of 13 Posts
Small Cap Biotechs Lead The Market In 2019 Up 20% YTD
Article By: Rod Raynovich Thursday, February 28, 2019 12:20 PM EDT
Gene Therapy stocks soar on Spark (ONCE) Deal: BLUE, CRSP, RARE; and XBI up 4.2%.
In this article: ONCE, RARE, DHR, GE, XBI, BLUE, CRSP, IWM, XLV, MRK, RHHBY, BMY, CELG, LOXO, LLY, GNMK, AMRN, TDOC
Read
5 Cheap Stocks With Robust Upside Ahead
Article By: TipRanks Monday, September 3, 2018 11:56 AM EDT
Let’s take a closer look at these 5 stocks.
In this article: MPC, DBX, WTW, LOXO, IOVA
Read
Biotech Stocks Emerge Unscathed And Ready To Go
Article By: Tarun Chandra, CFA Friday, May 18, 2018 8:41 PM EDT
The biotech stocks have been demonstrating strong resilience in the face of intense volatility since February and, remarkably, keeping pace with the broader indexes, considering the highly speculative and volatile nature of the group.
In this article: CVS, MRK, IBB, INCY, ESRX, XBI, ARNA, ECYT, IMMU, IRWD, DVAX, SUPN, SRPT, AGIO, QURE, HRTX, LOXO, ATRA, BGNE, ADAP, CRSP, CBIO, GTHX, MRTX
Read
Loxo Gains, Jounce Plunges After Cancer Meeting Abstracts Released
Article By: The Fly Thursday, May 17, 2018 5:10 PM EDT
Shares of Loxo Oncology jumped in after the biotech company released data in abstracts in anticipation of the 2018 American Society of Clinical Oncology Annual Meeting that is being held June 1-5 in Chicago.
In this article: LOXO Also: BMY, JNCE, NKTR
Read
Blueprint Sinks, Loxo Rises After Trial Data On Potential Solid Tumor Treatment
Article By: The Fly Monday, April 16, 2018 2:43 PM EDT
Shares of Blueprint Medicines are sliding after the company reported data over the weekend regarding its early-stage candidate in RET-altered tumors.
In this article: BPMC, LOXO
Read
Loxo Drops After Announcing Cancer Drug Co-Development Deal With Bayer
Article By: The Fly Tuesday, November 14, 2017 11:56 AM EDT
Shares of Loxo Oncology jumped in pre-market trading before reversing and heading lower after the company announced a partnership with Bayer to develop and commercialize its two lead drugs.
In this article: LOXO Also: BAYRY
Read
Late Slide In Tech Mega-Caps Leaves Averages Mixed For Week
Article By: The Fly Saturday, June 10, 2017 10:38 AM EDT
Stocks appeared in line for a slight weekly advance until Friday afternoon, when a sharp decline in a number of mega-cap tech stock pushed the Nasdaq down nearly 2.5% at its low point.
In this article: DFT, DHI, DLR, FOR, JWN, M, THO, VZ, CLDR, AMRI, GIII, NLNK, AAPL, AMZN, FRAN, GOOG, MSFT, YHOO, DVAX, JUNO, BABA, FB, AMBA, GLYC, KITE, BLUE, MIK, ANTM, PLAY, RDUS, LOXO, DLTH, HDS
Read
ASCO Update #2: Stock Performance Data As Of 6/8/17
Article By: Rod Raynovich Friday, June 9, 2017 6:24 PM EDT
Biotechnology stocks are driven by clinical and deal news so here are some trends to consider.
In this article: CLVS, XBI, PUMA, KITE, BLUE, LOXO
Read
Amid The Perceived Gloom In The Hedge Fund Universe, This Hedge Fund’s Stock Picks Gained 38.8% In Q1
Article By: Insider Monkey Wednesday, May 17, 2017 4:33 AM EDT
Since most hedge funds even today run a short portfolio alongside their long portfolios, the losses from their short positions eat into the returns of their long portfolio during bull markets and result in underperformance.
In this article: LOXO, FMI, SAGE Also: MYGN, SPY, NEO
Read
After Valeant, Here Are 5 Drug Stocks Bill Ackman Should Buy Instead
Article By: Arpita Dutt Wednesday, March 15, 2017 12:57 PM EDT
Here is a look at 5 drug stocks that could find a place in Ackman’s investment plans.
In this article: NEOS, CNCE, LOXO, NDRM, BCRX Also: VRX
Read
Loxo Oncology Announces Proposed Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire Wednesday, January 4, 2017 4:41 PM EDT
Loxo Oncology, Inc. announced today that it intends to offer shares of its common stock in an underwritten public offering. Loxo Oncology also expects to grant the underwriters a 30-day option to purchase additional shares of its common stock.
In this article: LOXO
Read
Loxo Oncology- Chart Of The Day
Article By: Jim Van Meerten Friday, November 13, 2015 2:40 AM EDT
Since the Trend Spotter signaled a buy on 10/15 the stock gained 21.99%.
In this article: LOXO
Read
Loxo Oncology - Chart Of The Day
Article By: Jim Van Meerten Thursday, September 10, 2015 5:38 PM EDT
Revenue expected to grow 36.90% this year.
In this article: LOXO
Read
1 to 13 of 13 Posts